🔎 Trials Near Me

Dachaigh › Glioblastoma › Massachusetts

Sgrùdaidhean clionaigeach Glioblastoma ann an Massachusetts

Tha 29 sgrùdaidhean airson Glioblastoma a’ lorg phàirtichean aig làraichean ann an Massachusetts.

Bailtean ann an Massachusetts

Teacsa sgrùdaidh oifigeil (Beurla)

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT03970447

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Massachusetts General Hospital, Boston
  • Beth Israel Deaconess Medical Center, Boston
  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07326566

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Dana Farber Cancer Institute., Boston
A’ fastadhÌre 1/2
Suas gu aois 25 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT04094610

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Tufts Medical Center, Boston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06047379

Anti-GD2 ADC M3554 in Advanced Solid Tumors

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06641908

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

  • Massachusetts General Hospital - Neurology, Boston
  • Dana-Farber Cancer Institute - Oncology Department, Boston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06914128

Targeted Pediatric High-Grade Glioma Therapy

  • Dana-Farber Cancer Institute, Boston
A’ fastadhSgrùdadh amharc
12 Months – 39 Years · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05839379

Serial MRI Scans During Radiation Therapy

  • Brigham and Women Hospital, Boston
  • Dana Farber Cancer Institute, Boston
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT04188535

Study of Olutasidenib and Temozolomide in HGG

  • Susan Chi, Boston
A’ fastadhÌre 2
Aoisean 12 gu 39 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT05303519

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT02977780

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 17 Iuch 2026 · NCT07225621

CARv3-TEAM-E T Cells in Glioblastoma

  • Massachusetts General Hospital Cancer Center, Boston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Iuch 2026 · NCT05660369

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Iuch 2026 · NCT06805305

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1 tràthFàilte do shaor-thoilich fhallain
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 2
12 Months – 39 Years · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT05843253

G-CSF After Chemo-radiation in Patients With Glioblastoma

  • Massachusetts General Hospital, Boston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06649851

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT06810544

CUE-102 in Recurrent Glioblastoma

  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Màrt 2026 · NCT06917885

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Worcester
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2025 · NCT05941507

Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial

  • Brigham and Women's Hospital, Boston
  • Dana-Farber Brigham Cancer Center, Milford Hospital, Milford
  • Dana-Farber Brigham Cancer Center, South Shore Hospital, South Weymouth
A’ fastadhÌre 2
Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2025 · NCT06835803

A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma

  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Massachusetts General Hospital Cancer Center, Boston
A’ fastadhÌre 1 tràth
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2025 · NCT06552260

Implantable Microdevice In Primary Brain Tumors

  • Brigham and Women's Hospital, Boston
A’ fastadhÌre 1 tràth
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Iuch 2025 · NCT04135807

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

  • Massachusetts General Hospital, Boston
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 28 Gearr 2024 · NCT06283927

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

  • Massachusetts General Hospital, Boston
A’ fastadhSgrùdadh amharc
Suas gu aois 90 · Gach gnè · Air ùrachadh 22 Gearr 2024 · NCT06273176

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

  • Massachusetts General Hospital, Boston
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 22 Gearr 2024 · NCT06118723

The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)

  • Massachusetts General Hospital, Boston
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 27 Samh 2023 · NCT06146738

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

  • Massachusetts General Hospital, Boston
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 27 Samh 2023 · NCT06146725

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.